Hans Bordado Henriksen

Artiklar

Article: METHODSX. 2024;13:102810
Off-label use of clomiphene citrate to treat anabolic androgenic steroid induced hypogonadism upon cessation among men (CloTASH) - A pilot study protocol
Havnes IA; Henriksen HCB; Johansen PW; Bjornebekk A; Neupane SP; Hisdal J; Seljeflot I; Wisloff C; Jorstad ML; McVeigh J; Jorgensen AP
Journal article: PERFORMANCE ENHANCEMENT AND HEALTH. 2024;12(3):100283
Clomiphene citrate and optional human chorionic gonadotropin for treating male hypogonadism arising from long-term anabolic-androgenic steroid use-A pilot study
Henriksen HCB; Jorgensen AP; Bjornebekk A; Neupane SP; Havnes IA
Article: DRUGS-EDUCATION PREVENTION AND POLICY. 2024;31(4):409-421
Challenges recruiting men with a desire to cease anabolic-androgenic steroid use to a pilot involving hormone therapy intervention
Henriksen HCB; Jorgensen A; Wisloff C; Havnes IA
Article: SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS. 2024;34(1):e14554
Treatment-seeking behavior and cardiovascular morbidity among men with anabolic-androgenic steroid use: A cross-sectional study
Henriksen HCB; Havnes IA; Jorstad ML; Abdullah R; Thorsby PM; Hauger LE; Edvardsen T; Haugaa KH; Almaas VM; Bjornebekk A
Article: SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY. 2023;18(1):19
Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study
Henriksen HCB; Havnes IA; Jorstad ML; Bjornebekk A